Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience - Luigi Gargiulo; Luciano Ibba; Carlo Alberto Vignoli; Paola Facheris; Mario Valenti; Antonio Costanzo; Alessandra Narcisi (Taylor & Francis Group, 2023)